|
Status |
Public on May 18, 2012 |
Title |
ZNF overexpression - Primary_2 |
Sample type |
RNA |
|
|
Channel 1 |
Source name |
Vector
|
Organism |
Mus musculus |
Characteristics |
expression: vector control cell type: primary mammary epithelial cells
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen RNeasy kit
|
Label |
Cy3
|
Label protocol |
Ambion MessageAmp II Amino Allyl kit
|
|
|
Channel 2 |
Source name |
ZNF217
|
Organism |
Mus musculus |
Characteristics |
expression: ZNF217 overexpression cell type: primary mammary epithelial cells
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen RNeasy kit
|
Label |
Cy5
|
Label protocol |
Ambion MessageAmp II Amino Allyl kit
|
|
|
|
Hybridization protocol |
Hybridize at 65°C for 14 to 18 hours.
|
Scan protocol |
Axon Instruments (V1.00) AxImageIO, GenePix 4000B
|
Data processing |
VALUE is Log (base 2) of the ratio of the median of Channel 2 (usually 635 nm) to Channel 1 (usually 532 nm).
|
|
|
Submission date |
Oct 15, 2010 |
Last update date |
May 18, 2012 |
Contact name |
Laurie Littlepage |
E-mail(s) |
laurie.littlepage@ucsf.edu
|
Phone |
415-476-4758
|
Organization name |
University of California, San Francisco
|
Department |
Anatomy
|
Lab |
Zena Werb
|
Street address |
513 Parnassus Avenue, Box 0452
|
City |
San Francisco |
State/province |
CA |
ZIP/Postal code |
94143 |
Country |
USA |
|
|
Platform ID |
GPL11062 |
Series (1) |
GSE24727 |
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression |
|